BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gerhardt S, Mohajeri MH. Changes of Colonic Bacterial Composition in Parkinson's Disease and Other Neurodegenerative Diseases. Nutrients 2018;10:E708. [PMID: 29857583 DOI: 10.3390/nu10060708] [Cited by in Crossref: 100] [Cited by in F6Publishing: 89] [Article Influence: 25.0] [Reference Citation Analysis]
Number Citing Articles
1 Lin X, Zhao J, Zhang W, He L, Wang L, Chang D, Cui L, Gao Y, Li B, Chen C, Li Y. Acute oral methylmercury exposure perturbs the gut microbiome and alters gut-brain axis related metabolites in rats. Ecotoxicology and Environmental Safety 2020;190:110130. [DOI: 10.1016/j.ecoenv.2019.110130] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 9.5] [Reference Citation Analysis]
2 Lorente-Picón M, Laguna A. New Avenues for Parkinson's Disease Therapeutics: Disease-Modifying Strategies Based on the Gut Microbiota. Biomolecules 2021;11:433. [PMID: 33804226 DOI: 10.3390/biom11030433] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Rich S, Klann E, Bryant V, Richards V, Wijayabahu A, Bryant K, Mai V, Cook R. A review of potential microbiome-gut-brain axis mediated neurocognitive conditions in persons living with HIV. Brain Behav Immun Health 2020;9:100168. [PMID: 34589903 DOI: 10.1016/j.bbih.2020.100168] [Reference Citation Analysis]
4 Zhao Z, Ning J, Bao XQ, Shang M, Ma J, Li G, Zhang D. Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis. Microbiome 2021;9:226. [PMID: 34784980 DOI: 10.1186/s40168-021-01107-9] [Reference Citation Analysis]
5 Narasimhan H, Ren CC, Deshpande S, Sylvia KE. Young at Gut-Turning Back the Clock with the Gut Microbiome. Microorganisms 2021;9:555. [PMID: 33800340 DOI: 10.3390/microorganisms9030555] [Reference Citation Analysis]
6 Babakhanov AT, Dzhumabekov AT, Zhao AV, Kuandykov YK, Tanabayeva SB, Fakhradiyev IR, Nazarenko Y, Saliev TM. Impact of Appendectomy on Gut Microbiota. Surg Infect (Larchmt) 2021;22:651-61. [PMID: 33523761 DOI: 10.1089/sur.2020.422] [Reference Citation Analysis]
7 Cox LM, Abou-El-Hassan H, Maghzi AH, Vincentini J, Weiner HL. The sex-specific interaction of the microbiome in neurodegenerative diseases. Brain Res 2019;1724:146385. [PMID: 31419428 DOI: 10.1016/j.brainres.2019.146385] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
8 Cheng Y, Liu J, Ling Z. Short-chain fatty acids-producing probiotics: A novel source of psychobiotics. Crit Rev Food Sci Nutr 2021;:1-31. [PMID: 33955288 DOI: 10.1080/10408398.2021.1920884] [Reference Citation Analysis]
9 Li R, Li Y, Li C, Zheng D, Chen P. Gut Microbiota and Endocrine Disorder. In: Chen P, editor. Gut Microbiota and Pathogenesis of Organ Injury. Singapore: Springer; 2020. pp. 143-64. [DOI: 10.1007/978-981-15-2385-4_9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Kong Y, Wang L, Jiang B. The Role of Gut Microbiota in Aging and Aging Related Neurodegenerative Disorders: Insights from Drosophila Model. Life (Basel) 2021;11:855. [PMID: 34440599 DOI: 10.3390/life11080855] [Reference Citation Analysis]
11 Verbrugghe P, Brynjólfsson J, Jing X, Björck I, Hållenius F, Nilsson A. Evaluation of hypoglycemic effect, safety and immunomodulation of Prevotella copri in mice. Sci Rep 2021;11:21279. [PMID: 34711895 DOI: 10.1038/s41598-021-96161-6] [Reference Citation Analysis]
12 Wallen ZD. Comparison study of differential abundance testing methods using two large Parkinson disease gut microbiome datasets derived from 16S amplicon sequencing. BMC Bioinformatics 2021;22:265. [PMID: 34034646 DOI: 10.1186/s12859-021-04193-6] [Reference Citation Analysis]
13 Koh YC, Lee PS, Kuo YL, Nagabhushanam K, Ho CT, Pan MH. Dietary Pterostilbene and Resveratrol Modulate the Gut Microbiota Influenced by Circadian Rhythm Dysregulation. Mol Nutr Food Res 2021;65:e2100434. [PMID: 34506670 DOI: 10.1002/mnfr.202100434] [Reference Citation Analysis]
14 Sun J, Li H, Jin Y, Yu J, Mao S, Su KP, Ling Z, Liu J. Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson's disease via gut microbiota-GLP-1 pathway. Brain Behav Immun 2021;91:703-15. [PMID: 33148438 DOI: 10.1016/j.bbi.2020.10.014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
15 Wasser CI, Mercieca EC, Kong G, Hannan AJ, McKeown SJ, Glikmann-Johnston Y, Stout JC. Gut dysbiosis in Huntington's disease: associations among gut microbiota, cognitive performance and clinical outcomes. Brain Commun 2020;2:fcaa110. [PMID: 33005892 DOI: 10.1093/braincomms/fcaa110] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
16 Vuotto C, Battistini L, Caltagirone C, Borsellino G. Gut Microbiota and Disorders of the Central Nervous System. Neuroscientist 2020;26:487-502. [PMID: 32441219 DOI: 10.1177/1073858420918826] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
17 Hewel C, Kaiser J, Wierczeiko A, Linke J, Reinhardt C, Endres K, Gerber S. Common miRNA Patterns of Alzheimer's Disease and Parkinson's Disease and Their Putative Impact on Commensal Gut Microbiota. Front Neurosci 2019;13:113. [PMID: 30890906 DOI: 10.3389/fnins.2019.00113] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
18 Boertien JM, Pereira PAB, Aho VTE, Scheperjans F. Increasing Comparability and Utility of Gut Microbiome Studies in Parkinson's Disease: A Systematic Review. J Parkinsons Dis 2019;9:S297-312. [PMID: 31498131 DOI: 10.3233/JPD-191711] [Cited by in Crossref: 55] [Cited by in F6Publishing: 29] [Article Influence: 27.5] [Reference Citation Analysis]
19 Takeshige-Amano H, Saiki S, Fujimaki M, Ueno SI, Li Y, Hatano T, Ishikawa KI, Oji Y, Mori A, Okuzumi A, Tsunemi T, Daida K, Ishiguro Y, Imamichi Y, Nanmo H, Nojiri S, Funayama M, Hattori N. Shared Metabolic Profile of Caffeine in Parkinsonian Disorders. Mov Disord 2020;35:1438-47. [PMID: 32357260 DOI: 10.1002/mds.28068] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Musco S, Bazzocchi G, Martellucci J, Amato MP, Manassero A, Putignano D, Lopatriello S, Cafiero D, Paoloni F, Del Popolo G. Treatments in neurogenic bowel dysfunctions: evidence reviews and clinical recommendations in adults. Eur J Phys Rehabil Med 2020;56:741-55. [PMID: 32935955 DOI: 10.23736/S1973-9087.20.06412-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Xia Y, Zhu J, Xu Y, Zhang H, Zou F, Meng X. Effects of ecologically relevant concentrations of cadmium on locomotor activity and microbiota in zebrafish. Chemosphere 2020;257:127220. [PMID: 32531487 DOI: 10.1016/j.chemosphere.2020.127220] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
22 Hegelmaier T, Lebbing M, Duscha A, Tomaske L, Tönges L, Holm JB, Bjørn Nielsen H, Gatermann SG, Przuntek H, Haghikia A. Interventional Influence of the Intestinal Microbiome Through Dietary Intervention and Bowel Cleansing Might Improve Motor Symptoms in Parkinson's Disease. Cells 2020;9:E376. [PMID: 32041265 DOI: 10.3390/cells9020376] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
23 Haran JP, McCormick BA. Aging, Frailty, and the Microbiome-How Dysbiosis Influences Human Aging and Disease. Gastroenterology 2021;160:507-23. [PMID: 33307030 DOI: 10.1053/j.gastro.2020.09.060] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
24 Yang C, Qiao Z, Xu Z, Wang X, Deng Q, Chen W, Huang F. Algal Oil Rich in Docosahexaenoic Acid Alleviates Intestinal Inflammation Induced by Antibiotics Associated with the Modulation of the Gut Microbiome and Metabolome. J Agric Food Chem 2021;69:9124-36. [PMID: 33900083 DOI: 10.1021/acs.jafc.0c07323] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Wang K, Tian Y, Zhang Y, Li X, Wei X, Hu H, Xu S. Toxicity mechanism of sevoflurane in neural stem cells of rats through DNA methylation. Exp Ther Med 2019;18:237-41. [PMID: 31281437 DOI: 10.3892/etm.2019.7553] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
26 Boeri L, Perottoni S, Izzo L, Giordano C, Albani D. Microbiota-Host Immunity Communication in Neurodegenerative Disorders: Bioengineering Challenges for In Vitro Modeling. Adv Healthc Mater 2021;10:e2002043. [PMID: 33661580 DOI: 10.1002/adhm.202002043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Maiuolo J, Gliozzi M, Musolino V, Carresi C, Scarano F, Nucera S, Scicchitano M, Oppedisano F, Bosco F, Ruga S, Zito MC, Macri R, Palma E, Muscoli C, Mollace V. The Contribution of Gut Microbiota-Brain Axis in the Development of Brain Disorders. Front Neurosci 2021;15:616883. [PMID: 33833660 DOI: 10.3389/fnins.2021.616883] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
28 Kohnert E, Kreutz C, Binder N, Hannibal L, Gorkiewicz G, Müller A, Storz MA, Huber R, Lederer AK. Changes in Gut Microbiota after a Four-Week Intervention with Vegan vs. Meat-Rich Diets in Healthy Participants: A Randomized Controlled Trial. Microorganisms 2021;9:727. [PMID: 33807447 DOI: 10.3390/microorganisms9040727] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Brown T, Sykes D, Allen AR. Implications of Breast Cancer Chemotherapy-Induced Inflammation on the Gut, Liver, and Central Nervous System. Biomedicines 2021;9:189. [PMID: 33668580 DOI: 10.3390/biomedicines9020189] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Liu G, Chen H, Chen J, Wang X, Gu Q, Yin Y. Effects of bifidobacteria-produced exopolysaccharides on human gut microbiota in vitro. Appl Microbiol Biotechnol 2019;103:1693-702. [DOI: 10.1007/s00253-018-9572-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
31 Zhao Z, Li F, Ning J, Peng R, Shang J, Liu H, Shang M, Bao XQ, Zhang D. Novel compound FLZ alleviates rotenone-induced PD mouse model by suppressing TLR4/MyD88/NF-κB pathway through microbiota-gut-brain axis. Acta Pharm Sin B 2021;11:2859-79. [PMID: 34589401 DOI: 10.1016/j.apsb.2021.03.020] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Bhattarai Y, Kashyap PC. Parkinson's disease: Are gut microbes involved? Am J Physiol Gastrointest Liver Physiol 2020;319:G529-40. [PMID: 32877215 DOI: 10.1152/ajpgi.00058.2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Kawashima Y, Watanabe E, Umeyama T, Nakajima D, Hattori M, Honda K, Ohara O. Optimization of Data-Independent Acquisition Mass Spectrometry for Deep and Highly Sensitive Proteomic Analysis. Int J Mol Sci 2019;20:E5932. [PMID: 31779068 DOI: 10.3390/ijms20235932] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
34 Tulisiak CT, Mercado G, Peelaerts W, Brundin L, Brundin P. Can infections trigger alpha-synucleinopathies? Prog Mol Biol Transl Sci 2019;168:299-322. [PMID: 31699323 DOI: 10.1016/bs.pmbts.2019.06.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
35 Li J, Zheng M, Shimoni O, Banks WA, Bush AI, Gamble JR, Shi B. Development of Novel Therapeutics Targeting the Blood-Brain Barrier: From Barrier to Carrier. Adv Sci (Weinh) 2021;:e2101090. [PMID: 34085418 DOI: 10.1002/advs.202101090] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
36 Trabjerg MS, Mørkholt AS, Lichota J, Oklinski MKE, Andersen DC, Jønsson K, Mørk K, Skjønnemand MN, Kroese LJ, Pritchard CEJ, Huijbers IJ, Gazerani P, Corthals A, Nieland JDV. Dysregulation of metabolic pathways by carnitine palmitoyl-transferase 1 plays a key role in central nervous system disorders: experimental evidence based on animal models. Sci Rep 2020;10:15583. [PMID: 32973137 DOI: 10.1038/s41598-020-72638-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
37 Lister T. Nutrition and Lifestyle Interventions for Managing Parkinson's Disease: A Narrative Review. J Mov Disord 2020;13:97-104. [PMID: 32498495 DOI: 10.14802/jmd.20006] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Wallen ZD, Appah M, Dean MN, Sesler CL, Factor SA, Molho E, Zabetian CP, Standaert DG, Payami H. Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens. NPJ Parkinsons Dis 2020;6:11. [PMID: 32566740 DOI: 10.1038/s41531-020-0112-6] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 16.5] [Reference Citation Analysis]
39 Dong XL, Wang X, Liu F, Liu X, Du ZR, Li RW, Xue CH, Wong KH, Wong WT, Zhao Q, Tang QJ. Polymannuronic acid prevents dopaminergic neuronal loss via brain-gut-microbiota axis in Parkinson's disease model. Int J Biol Macromol 2020;164:994-1005. [PMID: 32710966 DOI: 10.1016/j.ijbiomac.2020.07.180] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
40 Bindas AJ, Kulkarni S, Koppes RA, Koppes AN. Parkinson's disease and the gut: Models of an emerging relationship. Acta Biomater 2021:S1742-7061(21)00229-4. [PMID: 33857691 DOI: 10.1016/j.actbio.2021.03.071] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
41 Lee J, Allen J. Mother’s educational attainment and their young adult daughters’ fast food intake: The role of race/ethnicity. Health Care for Women International 2020;41:169-87. [DOI: 10.1080/07399332.2019.1669606] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
42 Choi JG, Huh E, Kim N, Kim DH, Oh MS. High-throughput 16S rRNA gene sequencing reveals that 6-hydroxydopamine affects gut microbial environment. PLoS One 2019;14:e0217194. [PMID: 31404072 DOI: 10.1371/journal.pone.0217194] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
43 Verbrugghe P, Van Aken O, Hållenius F, Nilsson A. Development of a real-time quantitative PCR method for detection and quantification of Prevotella copri. BMC Microbiol 2021;21:23. [PMID: 33430782 DOI: 10.1186/s12866-020-02063-4] [Reference Citation Analysis]
44 Angiolillo A, Gandaglia A, Arcaro A, Carpi A, Gentile F, Naso F, Di Costanzo A. Altered Blood Levels of Anti-Gal Antibodies in Alzheimer's Disease: A New Clue to Pathogenesis? Life (Basel) 2021;11:538. [PMID: 34207559 DOI: 10.3390/life11060538] [Reference Citation Analysis]
45 Vidal-Martinez G, Chin B, Camarillo C, Herrera GV, Yang B, Sarosiek I, Perez RG. A Pilot Microbiota Study in Parkinson's Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models. J Parkinsons Dis 2020;10:185-92. [PMID: 31561385 DOI: 10.3233/JPD-191693] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
46 Chen Y, Zhou J, Wang L. Role and Mechanism of Gut Microbiota in Human Disease. Front Cell Infect Microbiol 2021;11:625913. [PMID: 33816335 DOI: 10.3389/fcimb.2021.625913] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
47 Li Y, Shao L, Mou Y, Zhang Y, Ping Y. Sleep, circadian rhythm and gut microbiota: alterations in Alzheimer's disease and their potential links in the pathogenesis. Gut Microbes 2021;13:1957407. [PMID: 34520319 DOI: 10.1080/19490976.2021.1957407] [Reference Citation Analysis]
48 Ahmed S, Busetti A, Fotiadou P, Vincy Jose N, Reid S, Georgieva M, Brown S, Dunbar H, Beurket-Ascencio G, Delday MI, Ettorre A, Mulder IE. In vitro Characterization of Gut Microbiota-Derived Bacterial Strains With Neuroprotective Properties. Front Cell Neurosci 2019;13:402. [PMID: 31619962 DOI: 10.3389/fncel.2019.00402] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
49 Ojeda J, Ávila A, Vidal PM. Gut Microbiota Interaction with the Central Nervous System throughout Life. J Clin Med 2021;10:1299. [PMID: 33801153 DOI: 10.3390/jcm10061299] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
50 Lin X, Zhao J, Zhang W, He L, Wang L, Li H, Liu Q, Cui L, Gao Y, Chen C, Li B, Li YF. Towards screening the neurotoxicity of chemicals through feces after exposure to methylmercury or inorganic mercury in rats: A combined study using gut microbiome, metabolomics and metallomics. J Hazard Mater 2021;409:124923. [PMID: 33482478 DOI: 10.1016/j.jhazmat.2020.124923] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
51 Kohn N, Szopinska-Tokov J, Llera Arenas A, Beckmann CF, Arias-Vasquez A, Aarts E. Multivariate associative patterns between the gut microbiota and large-scale brain network connectivity. Gut Microbes 2021;13:2006586. [PMID: 34856861 DOI: 10.1080/19490976.2021.2006586] [Reference Citation Analysis]
52 Yousefi B, Kokhaei P, Mehranfar F, Bahar A, Abdolshahi A, Emadi A, Eslami M. The role of the host microbiome in autism and neurodegenerative disorders and effect of epigenetic procedures in the brain functions. Neurosci Biobehav Rev 2021:S0149-7634(21)00488-7. [PMID: 34742725 DOI: 10.1016/j.neubiorev.2021.10.046] [Reference Citation Analysis]
53 Tran SM, Mohajeri MH. The Role of Gut Bacterial Metabolites in Brain Development, Aging and Disease. Nutrients 2021;13:732. [PMID: 33669008 DOI: 10.3390/nu13030732] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
54 Wallen ZD, Stone WJ, Factor SA, Molho E, Zabetian CP, Standaert DG, Payami H. Exploring human-genome gut-microbiome interaction in Parkinson's disease. NPJ Parkinsons Dis 2021;7:74. [PMID: 34408160 DOI: 10.1038/s41531-021-00218-2] [Reference Citation Analysis]
55 Yemula N, Dietrich C, Dostal V, Hornberger M. Parkinson's Disease and the Gut: Symptoms, Nutrition, and Microbiota. J Parkinsons Dis 2021. [PMID: 34250955 DOI: 10.3233/JPD-212707] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Holingue C, Budavari AC, Rodriguez KM, Zisman CR, Windheim G, Fallin MD. Sex Differences in the Gut-Brain Axis: Implications for Mental Health. Curr Psychiatry Rep 2020;22:83. [PMID: 33216233 DOI: 10.1007/s11920-020-01202-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
57 Di Meo F, Valentino A, Petillo O, Peluso G, Filosa S, Crispi S. Bioactive Polyphenols and Neuromodulation: Molecular Mechanisms in Neurodegeneration. Int J Mol Sci 2020;21:E2564. [PMID: 32272735 DOI: 10.3390/ijms21072564] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
58 Boulos C, Yaghi N, El Hayeck R, Heraoui GN, Fakhoury-Sayegh N. Nutritional Risk Factors, Microbiota and Parkinson's Disease: What Is the Current Evidence? Nutrients 2019;11:E1896. [PMID: 31416163 DOI: 10.3390/nu11081896] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
59 Tu T, Zhao C. Treating autism spectrum disorder by intervening with gut microbiota. J Med Microbiol 2021;70. [PMID: 34898421 DOI: 10.1099/jmm.0.001469] [Reference Citation Analysis]
60 Casani-Cubel J, Benlloch M, Sanchis-Sanchis CE, Marin R, Lajara-Romance JM, de la Rubia Orti JE. The Impact of Microbiota on the Pathogenesis of Amyotrophic Lateral Sclerosis and the Possible Benefits of Polyphenols. An Overview. Metabolites 2021;11:120. [PMID: 33672485 DOI: 10.3390/metabo11020120] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
61 Rosario D, Bidkhori G, Lee S, Bedarf J, Hildebrand F, Le Chatelier E, Uhlen M, Ehrlich SD, Proctor G, Wüllner U, Mardinoglu A, Shoaie S. Systematic analysis of gut microbiome reveals the role of bacterial folate and homocysteine metabolism in Parkinson's disease. Cell Rep 2021;34:108807. [PMID: 33657381 DOI: 10.1016/j.celrep.2021.108807] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
62 Uzbay T. Germ-free animal experiments in the gut microbiota studies. Current Opinion in Pharmacology 2019;49:6-10. [DOI: 10.1016/j.coph.2019.03.016] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
63 Walker AC, Bhargava R, Vaziriyan-Sani AS, Pourciau C, Donahue ET, Dove AS, Gebhardt MJ, Ellward GL, Romeo T, Czyż DM. Colonization of the Caenorhabditis elegans gut with human enteric bacterial pathogens leads to proteostasis disruption that is rescued by butyrate. PLoS Pathog 2021;17:e1009510. [PMID: 33956916 DOI: 10.1371/journal.ppat.1009510] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
64 Miraglia F, Colla E. Microbiome, Parkinson's Disease and Molecular Mimicry. Cells 2019;8:E222. [PMID: 30866550 DOI: 10.3390/cells8030222] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
65 Lubomski M, Tan AH, Lim SY, Holmes AJ, Davis RL, Sue CM. Parkinson's disease and the gastrointestinal microbiome. J Neurol 2020;267:2507-23. [PMID: 31041582 DOI: 10.1007/s00415-019-09320-1] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 14.3] [Reference Citation Analysis]
66 Tinkov AA, Martins AC, Avila DS, Gritsenko VA, Skalny AV, Santamaria A, Lee E, Bowman AB, Aschner M. Gut Microbiota as a Potential Player in Mn-Induced Neurotoxicity. Biomolecules 2021;11:1292. [PMID: 34572505 DOI: 10.3390/biom11091292] [Reference Citation Analysis]
67 Kujawska M, Jodynis-Liebert J. What is the Evidence That Parkinson's Disease is a Prion Disorder, Which Originates in the Gut? Int J Mol Sci 2018;19:E3573. [PMID: 30424585 DOI: 10.3390/ijms19113573] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
68 Urrutia A, García-Angulo VA, Fuentes A, Caneo M, Legüe M, Urquiza S, Delgado SE, Ugalde J, Burdisso P, Calixto A. Bacterially produced metabolites protect C. elegans neurons from degeneration. PLoS Biol 2020;18:e3000638. [PMID: 32208418 DOI: 10.1371/journal.pbio.3000638] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
69 Sun BL, Li WW, Wang J, Xu YL, Sun HL, Tian DY, Wang YJ, Yao XQ. Gut Microbiota Alteration and Its Time Course in a Tauopathy Mouse Model. J Alzheimers Dis 2019;70:399-412. [PMID: 31177213 DOI: 10.3233/JAD-181220] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
70 Sarkar A, Yoo JY, Valeria Ozorio Dutra S, Morgan KH, Groer M. The Association between Early-Life Gut Microbiota and Long-Term Health and Diseases. J Clin Med 2021;10:459. [PMID: 33504109 DOI: 10.3390/jcm10030459] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 15.0] [Reference Citation Analysis]
71 Lei Q, Wu T, Wu J, Hu X, Guan Y, Wang Y, Yan J, Shi G. Roles of α‑synuclein in gastrointestinal microbiome dysbiosis‑related Parkinson's disease progression (Review). Mol Med Rep 2021;24:734. [PMID: 34414447 DOI: 10.3892/mmr.2021.12374] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Munoz-Pinto MF, Empadinhas N, Cardoso SM. The neuromicrobiology of Parkinson's disease: A unifying theory. Ageing Res Rev 2021;70:101396. [PMID: 34171417 DOI: 10.1016/j.arr.2021.101396] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
73 Trabjerg MS, Andersen DC, Huntjens P, Oklinski KE, Bolther L, Hald JL, Baisgaard AE, Mørk K, Warming N, Kullab UB, Kroese LJ, Pritchard CEJ, Huijbers IJ, Nieland JDV. Downregulating carnitine palmitoyl transferase 1 affects disease progression in the SOD1 G93A mouse model of ALS. Commun Biol 2021;4:509. [PMID: 33931719 DOI: 10.1038/s42003-021-02034-z] [Reference Citation Analysis]
74 Moreno-Arrones OM, Ortega-Quijano D, Perez-Brocal V, Fernandez-Nieto D, Jimenez N, de Las Heras E, Moya A, Perez-Garcia B. Dysbiotic gut microbiota in patients with inflammatory rosacea: another clue towards the existence of a brain-gut-skin axis. Br J Dermatol 2021;185:655-7. [PMID: 33913159 DOI: 10.1111/bjd.20411] [Reference Citation Analysis]
75 Huang Y, Liao J, Liu X, Zhong Y, Cai X, Long L. Review: The Role of Intestinal Dysbiosis in Parkinson's Disease. Front Cell Infect Microbiol 2021;11:615075. [PMID: 33968794 DOI: 10.3389/fcimb.2021.615075] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
76 Weinberg RP, Koledova VV, Subramaniam A, Schneider K, Artamonova A, Sambanthamurthi R, Hayes KC, Sinskey AJ, Rha C. Palm Fruit Bioactives augment expression of Tyrosine Hydroxylase in the Nile Grass Rat basal ganglia and alter the colonic microbiome. Sci Rep 2019;9:18625. [PMID: 31819070 DOI: 10.1038/s41598-019-54461-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
77 Dănău A, Dumitrescu L, Lefter A, Tulbă D, Popescu BO. Small Intestinal Bacterial Overgrowth as Potential Therapeutic Target in Parkinson's Disease. Int J Mol Sci 2021;22:11663. [PMID: 34769091 DOI: 10.3390/ijms222111663] [Reference Citation Analysis]
78 Song S, Liu J, Zhang F, Hong JS. Norepinephrine depleting toxin DSP-4 and LPS alter gut microbiota and induce neurotoxicity in α-synuclein mutant mice. Sci Rep 2020;10:15054. [PMID: 32929122 DOI: 10.1038/s41598-020-72202-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
79 Kirby TO, Ochoa-Repáraz J. The Gut Microbiome in Multiple Sclerosis: A Potential Therapeutic Avenue. Med Sci (Basel) 2018;6:E69. [PMID: 30149548 DOI: 10.3390/medsci6030069] [Cited by in Crossref: 22] [Cited by in F6Publishing: 28] [Article Influence: 5.5] [Reference Citation Analysis]
80 Rosario D, Boren J, Uhlen M, Proctor G, Aarsland D, Mardinoglu A, Shoaie S. Systems Biology Approaches to Understand the Host-Microbiome Interactions in Neurodegenerative Diseases. Front Neurosci 2020;14:716. [PMID: 32733199 DOI: 10.3389/fnins.2020.00716] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
81 Zarghami A, Li Y, Claflin SB, van der Mei I, Taylor BV. Role of environmental factors in multiple sclerosis. Expert Rev Neurother 2021;:1-20. [PMID: 34494502 DOI: 10.1080/14737175.2021.1978843] [Reference Citation Analysis]
82 Brudek T. Inflammatory Bowel Diseases and Parkinson's Disease. J Parkinsons Dis 2019;9:S331-44. [PMID: 31609699 DOI: 10.3233/JPD-191729] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 11.0] [Reference Citation Analysis]
83 Mohajeri MH. Brain Aging and Gut⁻Brain Axis. Nutrients 2019;11:E424. [PMID: 30781628 DOI: 10.3390/nu11020424] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
84 Dam B, Misra A, Banerjee S. Role of Gut Microbiota in Combating Oxidative Stress. In: Chakraborti S, Chakraborti T, Chattopadhyay D, Shaha C, editors. Oxidative Stress in Microbial Diseases. Singapore: Springer; 2019. pp. 43-82. [DOI: 10.1007/978-981-13-8763-0_4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 2.7] [Reference Citation Analysis]
85 Fakhri S, Yarmohammadi A, Yarmohammadi M, Farzaei MH, Echeverria J. Marine Natural Products: Promising Candidates in the Modulation of Gut-Brain Axis towards Neuroprotection. Mar Drugs 2021;19:165. [PMID: 33808737 DOI: 10.3390/md19030165] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
86 Wu G, Zhao N, Zhang C, Lam YY, Zhao L. Guild-based analysis for understanding gut microbiome in human health and diseases. Genome Med. 2021;13:22. [PMID: 33563315 DOI: 10.1186/s13073-021-00840-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
87 Ren X, Chen JF. Caffeine and Parkinson's Disease: Multiple Benefits and Emerging Mechanisms. Front Neurosci 2020;14:602697. [PMID: 33390888 DOI: 10.3389/fnins.2020.602697] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
88 Klann EM, Dissanayake U, Gurrala A, Farrer M, Shukla AW, Ramirez-zamora A, Mai V, Vedam-mai V. The Gut–Brain Axis and Its Relation to Parkinson’s Disease: A Review. Front Aging Neurosci 2022;13:782082. [DOI: 10.3389/fnagi.2021.782082] [Reference Citation Analysis]
89 Bazzocchi G, Turroni S, Bulzamini MC, D'Amico F, Bava A, Castiglioni M, Cagnetta V, Losavio E, Cazzaniga M, Terenghi L, De Palma L, Frasca G, Aiachini B, Cremascoli S, Massone A, Oggerino C, Onesta MP, Rapisarda L, Pagliacci MC, Biscotto S, Scarazzato M, Giovannini T, Balloni M, Candela M, Brigidi P, Kiekens C. Changes in gut microbiota in the acute phase after spinal cord injury correlate with severity of the lesion. Sci Rep 2021;11:12743. [PMID: 34140572 DOI: 10.1038/s41598-021-92027-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
90 Bhattarai Y, Si J, Pu M, Ross OA, McLean PJ, Till L, Moor W, Grover M, Kandimalla KK, Margolis KG, Farrugia G, Kashyap PC. Role of gut microbiota in regulating gastrointestinal dysfunction and motor symptoms in a mouse model of Parkinson's disease. Gut Microbes 2021;13:1866974. [PMID: 33459114 DOI: 10.1080/19490976.2020.1866974] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
91 Wu S, Liu X, Jiang R, Yan X, Ling Z. Roles and Mechanisms of Gut Microbiota in Patients With Alzheimer's Disease. Front Aging Neurosci 2021;13:650047. [PMID: 34122039 DOI: 10.3389/fnagi.2021.650047] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
92 Butler MI, Mörkl S, Sandhu KV, Cryan JF, Dinan TG. The Gut Microbiome and Mental Health: What Should We Tell Our Patients?: Le microbiote Intestinal et la Santé Mentale : que Devrions-Nous dire à nos Patients? Can J Psychiatry 2019;64:747-60. [PMID: 31530002 DOI: 10.1177/0706743719874168] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
93 Bull-Larsen S, Mohajeri MH. The Potential Influence of the Bacterial Microbiome on the Development and Progression of ADHD. Nutrients 2019;11:E2805. [PMID: 31744191 DOI: 10.3390/nu11112805] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
94 Li H, Ni J, Qing H. Gut Microbiota: Critical Controller and Intervention Target in Brain Aging and Cognitive Impairment. Front Aging Neurosci 2021;13:671142. [PMID: 34248602 DOI: 10.3389/fnagi.2021.671142] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
95 Mihaila D, Donegan J, Barns S, LaRocca D, Du Q, Zheng D, Vidal M, Neville C, Uhlig R, Middleton FA. The oral microbiome of early stage Parkinson's disease and its relationship with functional measures of motor and non-motor function. PLoS One 2019;14:e0218252. [PMID: 31247001 DOI: 10.1371/journal.pone.0218252] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
96 Endres K. Amyloidogenic Peptides in Human Neuro-Degenerative Diseases and in Microorganisms: A Sorrow Shared Is a Sorrow Halved? Molecules 2020;25:E925. [PMID: 32093040 DOI: 10.3390/molecules25040925] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
97 Castelli V, d'Angelo M, Lombardi F, Alfonsetti M, Antonosante A, Catanesi M, Benedetti E, Palumbo P, Cifone MG, Giordano A, Desideri G, Cimini A. Effects of the probiotic formulation SLAB51 in in vitro and in vivo Parkinson's disease models. Aging (Albany NY) 2020;12:4641-59. [PMID: 32155131 DOI: 10.18632/aging.102927] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 16.0] [Reference Citation Analysis]